AzTrials
AzTrials

SuicideFSPSNCT03488602

Focused Suicide Prevention Strategy for Youth

A study testing F-SPS+UC and EUC in people with Suicide and Suicide, Attempted, run by The Hospital for Sick Children at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study evaluates whether a Family-centered suicide prevention strategy, when added to usual care (F-SPS + UC), is more effective than enhanced usual care (EUC) in reducing suicide-related behaviors in 128 youth at high-risk of suicide. Read more about this study

Who is it for?
Ages 12 to 18 years
Conditions the study is for
Suicide, Suicide, Attempted, Suicidal Ideation
What is being tested?
F-SPS+UC and EUC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteCanada
Study dates
1 Mar 2018to Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Ages 12 to18 years
  • Youth presenting in the Emergency Department with acute suicidal ideation or suicide risk behaviour
  • SIQ-Jr score ≥ 31
  • Parent or caregiver able to communicate in English, or is willing to communicate using a hospital-organized translator, and willing to participate in study
  • Living in the greater Toronto area and access to a telephone.

Who cannot join

  • Active psychosis or hypomania/mania
  • Moderate to severe intellectual disability, autism.

Trial locations and contacts

1 site in 1 country.

Canada1 site, 1 recruiting
  • Matthew Tracey

    Toronto, Ontario, M5G 1X8

    Matthew Tracey, MA, 4165358501 ext. 201575, matthew.tracey@sickkids.ca

    Reva Schachter, MSc, 4165358501 ext. 201469, reva.schachter@sickkids.ca

    Recruiting

Other trials in Canada

About this study

Official title: A Focused Suicide Prevention Strategy for Youth Presenting to the Emergency Department With Suicide Related Behaviour: A Randomized Controlled Trial

This study evaluates whether a Family-centered suicide prevention strategy, when added to usual care (F-SPS + UC), is more effective than enhanced usual care (EUC) in reducing suicide-related behaviors in 128 youth at high-risk of suicide. Half of the participants will be randomized to receive F-SPS + UC and half will receive EUC.

Read the detailed description

This is a RCT of a patient- and family-centered suicide prevention intervention added to usual care (F-SPS + UC) for adolescents aged 12 to 18 years who present to the Emergency Department (ED) with suicidal ideation or suicide risk behaviours. The investigators will determine whether the F-SPS + UC intervention is more effective than enhanced usual care (EUC) in reducing suicide-related behaviors in 128 youth at high-risk of suicide.

F-SPS is a 6-week, standardized, manualized outpatient program that teaches participants to the skills to manage suicidal thoughts and impulses effectively. The family component addresses conflictual relationships that may be present in the family as well as improving family communication.

Enhanced usual care consists of 6 weekly telephone calls to ensure that the participant has connected with community resources suggested by the ED team and provide additional resources as needed.

Being tested
F-SPS+UC, EUC
Medical subject headings
Suicide, Suicide, Attempted, Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • F-SPS+UCBehavioural

    Also called F-SPS + UC

    Manualized individual and family program. Weekly individual and family sessions with a therapist for 6 weeks.

    Participants will continue to receive usual care.

  • EUCBehavioural

    Weekly telephone contact with parents regarding participant health care utilization. Referrals to community mental health resources provided as needed.

    Participants will continue to receive usual care.

Study groups in NCT03488602
Study groupRoleWhat they receive
F-SPS InterventionExperimentalThis group will receive the F-SPS intervention.
Receives: Behavioral: F-SPS+UC
Enhanced Usual Care (EUC)Active comparatorThis group will receive Enhanced Usual Care (EUC)
Receives: Behavioral: EUC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in suicidal ideation severity as measured by the Suicidal Ideation Questionnaire - Jr

    a 15-item measure self-report of suicide ideation (e.g., thoughts about death and dying) completed by the patient. Items are scored from 0 to 6, yielding a score from 0 to 90. Higher scores indicate more severe suicidal ideation.

    Measured: Screening, 6 weeks, 24 weeks

Secondary outcomes (7)
  1. Change in suicide related behavior as measured by the Suicide Behavior Questionnaire - Revised

    A 4-item self-report questionnaire that measures suicide behavior, and yields a total score of 3 - 18. Higher scores indicate more severe suicidal behavior.

    Measured: Screening, 6 weeks, 24 weeks

  2. Changes in emotional regulation using the Life Problems Inventory

    A 60-item self-report scale that measures emotional regulation on a 5 point Likert scale from 1 to 5. Higher scores indicate more impaired emotional regulation. The measure has four subscales: Confusion about Self, Impulsivity, Emotion Dysregulation, and Interpersonal Chaos. Each subscale has a score from 15 to 75 where a higher score indicates more severity.

    Measured: Baseline, 6 weeks, 24 weeks

  3. Change in family conflict as measured by the Conflict Behavior Questionnaire

    A 20-item scale that examines the parent-child relationship using true/false ratings, yielding a total score of 0 to 20. Higher scores This measure is completed by both the youth and the parent(s) or caregiver. Higher scores indicate more severe family conflict.

    Measured: Baseline, 6 weeks, 24 weeks

  4. Changes in global impairment as measured by the Columbia Impairment Scale

    A 13-item scale designed to measure functioning on a 5 point Likert scale from 0 to 4, yielding a total score of 0 to 52. This measure is completed by both the youth and the parent(s) or caregiver. Higher scores indicate more severe impairment.

    Measured: Baseline, 6 weeks, 24 weeks

  5. Changes in affect regulation as measured by the Children's Affective Lability Scale

    A 20-item parent-report instrument that measures difficulties with emotion regulation on 5 point Likert scale from 0 to 4, yielding a score from 0 to 80. Higher scores indicate more severe affective lability.

    Measured: Baseline, 6 weeks, 24 weeks

  6. Health Care Utilization Survey

    A parent-report qualitative interview of a youth's use of available health care services, medication, and the costs associated with those services.

    Measured: Baseline, 24 weeks

  7. Usual Care Tracking Survey

    A parent-report qualitative interview of a youth's use of available health care services over a 1 week period of time.

    Measured: Week 1, Week 2, Week 3, Week 4, Week 5, Week 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2018
  2. Study start1 Mar 2018
  3. Primary completionFeb 2020 (estimated)
  4. Study completionJul 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03488602
Sponsor's protocol ID
1000056892
Acronym
FSPS
Status last verified
Mar 2018
First submitted
8 Feb 2018
Last updated
5 Apr 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.

    PubMed 33884617
  • Tracey M, Finkelstein Y, Schachter R, Cleverley K, Monga S, Barwick M, Szatmari P, Moretti ME, Willan A, Henderson J, Korczak DJ. Recruitment of adolescents with suicidal ideation in the emergency department: lessons from a randomized controlled pilot trial of a youth suicide prevention intervention. BMC Med Res Methodol. 2020 Sep 14;20(1):231. doi: 10.1186/s12874-020-01117-5.

    PubMed 32928140
  • Korczak DJ, Finkelstein Y, Barwick M, Chaim G, Cleverley K, Henderson J, Monga S, Moretti ME, Willan A, Szatmari P. A suicide prevention strategy for youth presenting to the emergency department with suicide related behaviour: protocol for a randomized controlled trial. BMC Psychiatry. 2020 Jan 14;20(1):20. doi: 10.1186/s12888-019-2422-y.

    PubMed 31937274

Questions about this trial

What is this clinical trial studying?

A study testing F-SPS+UC and EUC in people with Suicide and Suicide, Attempted, run by The Hospital for Sick Children at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Matthew Tracey, MA (4165358501 ext. 201575, matthew.tracey@sickkids.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in suicidal ideation severity as measured by the Suicidal Ideation Questionnaire - Jr (time frame: Screening, 6 weeks, 24 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03488602, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in